Huntington Medical Research Institutes   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Pasadena CA United States (1952)

Organization Overview

First Clinical Trial
2008
NCT00753467
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Huntington Medical Research Institutes | Huntington Medical Research Institutes - Liver Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Cognitive Dysfunction (Phase 2)

Fatty Liver (Phase 4)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Liver Diseases (Phase 4)

Non-alcoholic Fatty Liver Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5